Incyte/$INCY
About Incyte
Ticker
Industry
Employees
Incyte Metrics
$14B
487.70
$0.15
0.73
-
Price and volume
Market cap
$14B
Beta
0.73
52-week high
$82.15
52-week low
$50.35
Average daily volume
1.8M
Financial strength
Current ratio
1.983
Quick ratio
1.598
Long term debt to equity
0.89
Total debt to equity
1.151
Interest coverage (TTM)
-5.59%
Management effectiveness
Return on assets (TTM)
-0.12%
Return on equity (TTM)
0.80%
Valuation
Price to earnings (TTM)
487.701
Price to revenue (TTM)
3.815
Price to book
4.4
Price to tangible book (TTM)
4.82
Price to free cash flow (TTM)
925.542
Growth
Revenue change (TTM)
12.94%
Earnings per share change (TTM)
-92.12%
3-year revenue growth (CAGR)
11.85%
3-year earnings per share growth (CAGR)
-60.52%
What the Analysts think about Incyte
Analyst Ratings
Incyte Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
Incyte Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
Incyte News
Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025
Incyte Highlights Commercial Growth, Clinical Progress and 2025 Milestones at the 43rd Annual J.P. Morgan Healthcare Conference
Incyte: Multiple Drug Launches Bode Well For Future Growth
FAQs
What’s the current market cap for Incyte stock?
What is the P/E ratio for Incyte stock?
Does Incyte stock pay dividends?
No, Incyte (INCY) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Incyte dividend payment date?
Incyte (INCY) stock does not pay dividends to its shareholders.
What is the beta indicator for Incyte?
Incyte (INCY) has a beta rating of 0.73. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.